Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2000 1
2002 2
2003 1
2004 1
2005 1
2006 2
2007 1
2009 1
2011 1
2012 1
2013 3
2014 5
2015 2
2016 4
2017 4
2018 4
2019 1
2020 8
2021 9
2022 8
2023 4

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Nausea and vomiting in early pregnancy.
Festin M. Festin M. BMJ Clin Evid. 2014 Mar 19;2014:1405. BMJ Clin Evid. 2014. PMID: 24646807 Free PMC article. Review.
INTRODUCTION: More than half of pregnant women suffer from nausea and vomiting, which typically begins by the fourth week and disappears by the 16th week of pregnancy. The cause of nausea and vomiting in pregnancy is unknown, but may be due to the rise in human chor …
INTRODUCTION: More than half of pregnant women suffer from nausea and vomiting, which typically begins by the fourth week and disappears by …
Ondansetron and metoclopramide as second-line antiemetics in women with nausea and vomiting in pregnancy: the EMPOWER pilot factorial RCT.
Robson S, McParlin C, Mossop H, Lie M, Fernandez-Garcia C, Howel D, Graham R, Ternent L, Steel A, Goudie N, Nadeem A, Phillipson J, Shehmar M, Simpson N, Tuffnell D, Campbell I, Williams R, O'Hara ME, McColl E, Nelson-Piercy C. Robson S, et al. Health Technol Assess. 2021 Nov;25(63):1-116. doi: 10.3310/hta25630. Health Technol Assess. 2021. PMID: 34782054 Free article. Clinical Trial.
Guidelines on the use of anti-sickness drugs exist, but evidence is limited about which drugs work the best. The EMPOWER (EMesis in Pregnancy - Ondansetron With mEtoClopRamide) trial aimed to compare the clinical effectiveness and cost-effectiveness of two anti-sick …
Guidelines on the use of anti-sickness drugs exist, but evidence is limited about which drugs work the best. The EMPOWER (EMesis in Pregn …
Ondansetron and pregnancy: Understanding the data.
Kennedy D. Kennedy D. Obstet Med. 2016 Mar;9(1):28-33. doi: 10.1177/1753495X15621154. Epub 2015 Dec 23. Obstet Med. 2016. PMID: 27512487 Free PMC article. Review.
Following the thalidomide tragedy of 55 years ago there is a particular awareness and sensitivity about these potential risks, especially in relation to any medication used to treat NVP. Despite several studies showing no clear benefits of ondansetron over other NVP treatm …
Following the thalidomide tragedy of 55 years ago there is a particular awareness and sensitivity about these potential risks, especially in …
Interventions for treating hyperemesis gravidarum: a Cochrane systematic review and meta-analysis.
Boelig RC, Barton SJ, Saccone G, Kelly AJ, Edwards SJ, Berghella V. Boelig RC, et al. J Matern Fetal Neonatal Med. 2018 Sep;31(18):2492-2505. doi: 10.1080/14767058.2017.1342805. Epub 2017 Jul 11. J Matern Fetal Neonatal Med. 2018. PMID: 28614956 Review.
INTRODUCTION: While nausea and vomiting in early pregnancy are very common, affecting approximately 80% of the pregnancies, hyperemesis gravidarum is a severe form affecting 0.3-1.0% of the pregnancies. ...It is one of the most common indications for hospital …
INTRODUCTION: While nausea and vomiting in early pregnancy are very common, affecting approximately 80% of the pregnancies, hy …
Medical treatment for acute renal colic.
de la Encarnación Castellano C, Canós Nebot À, Caballero Romeu JP, Galán Llopis JA. de la Encarnación Castellano C, et al. Arch Esp Urol. 2021 Jan;74(1):71-79. Arch Esp Urol. 2021. PMID: 33459623 Free article. English, Spanish.
AIMS: The main objective of our work is to evaluate the effectiveness and safety profile of the different drugs used in the treatment of CCR and to propose a practical treatment scheme. ...The control of vegetative cortex can be accomplished with Ondansetron as firs …
AIMS: The main objective of our work is to evaluate the effectiveness and safety profile of the different drugs used in the treatment …
Ondansetron use in early pregnancy and the risk of miscarriage.
Suarez EA, Boggess K, Engel SM, Stürmer T, Lund JL, Jonsson Funk M. Suarez EA, et al. Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):103-113. doi: 10.1002/pds.5143. Epub 2020 Oct 12. Pharmacoepidemiol Drug Saf. 2021. PMID: 33000871
BACKGROUND: Ondansetron is commonly used to treat nausea and vomiting in pregnancy despite inconclusive evidence of its safety. ...CONCLUSIONS: We did not observe an increase in the risk of miscarriage for pregnancies exposed to ondansetron vs c …
BACKGROUND: Ondansetron is commonly used to treat nausea and vomiting in pregnancy despite inconclusive evidence of its saf …
Ondansetron Use in Pregnancy.
Siminerio LL, Bodnar LM, Venkataramanan R, Caritis SN. Siminerio LL, et al. Obstet Gynecol. 2016 May;127(5):873-877. doi: 10.1097/AOG.0000000000001375. Obstet Gynecol. 2016. PMID: 27054931 Free PMC article.
An efficacious treatment used widely across the United States for both nausea and vomiting of pregnancy and hyperemesis gravidarum is ondansetron. Recent studies have provided conflicting findings on the safety of ondansetron during pregnancy. T …
An efficacious treatment used widely across the United States for both nausea and vomiting of pregnancy and hyperemesis gravidarum is …
Managing Migraine During Pregnancy and Lactation.
Wells RE, Turner DP, Lee M, Bishop L, Strauss L. Wells RE, et al. Curr Neurol Neurosci Rep. 2016 Apr;16(4):40. doi: 10.1007/s11910-016-0634-9. Curr Neurol Neurosci Rep. 2016. PMID: 27002079 Review.
Non-pharmacological migraine treatments can be instituted in advance of pregnancy as many are considered the safest options during pregnancy, but understanding the safety of medications and dietary supplements ensures appropriate care for the refractory migra …
Non-pharmacological migraine treatments can be instituted in advance of pregnancy as many are considered the safest options during …
Ondansetron use in nausea and vomiting during pregnancy: A descriptive analysis of prescription patterns and patient characteristics in UK general practice.
Slattery J, Quinten C, Candore G, Pinheiro L, Flynn R, Kurz X, Nordeng H. Slattery J, et al. Br J Clin Pharmacol. 2022 Oct;88(10):4526-4539. doi: 10.1111/bcp.15370. Epub 2022 May 17. Br J Clin Pharmacol. 2022. PMID: 35483963 Free PMC article.
AIMS: The objective of this study was to describe ondansetron drug utilization patterns during pregnancy to treat nausea and vomiting in pregnancy (NVP). ...Descriptive statistics were used to investigate patterns of ondansetron use in pregnancy …
AIMS: The objective of this study was to describe ondansetron drug utilization patterns during pregnancy to treat nausea and v …
The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study.
Einarson A, Maltepe C, Navioz Y, Kennedy D, Tan MP, Koren G. Einarson A, et al. BJOG. 2004 Sep;111(9):940-3. doi: 10.1111/j.1471-0528.2004.00236.x. BJOG. 2004. PMID: 15327608
Despite the fact that it is not indicated, women are being prescribed this drug for the treatment of nausea and vomiting of pregnancy (NVP). There is a paucity of information on fetal safety for this indication. ...MAIN OUTCOME MEASURE: Rates of major malformation. …
Despite the fact that it is not indicated, women are being prescribed this drug for the treatment of nausea and vomiting of pregnancy …
56 results